Semaglutide weight loss

Novo Nordisk’s Higher-Dose Semaglutide Shows Promising Weight Loss Results

Novo Nordisk is exploring a higher-dose version of semaglutide to enhance weight loss treatments. In a recent phase 3b clinical trial called STEP UP, a 7.2-mg weekly dose of semaglutide helped participants lose an average of 20.7% of their body weight over 72 weeks. This significantly outperformed the 2.4-mg dose marketed as Wegovy, which led

Mental Health and Self-Care: Thriving During the Holidays

The holiday season is often seen as a joyful time, but for many, it can also bring stress, anxiety, or feelings of loneliness. Between the pressure of planning, social obligations, and personal expectations, it’s easy to feel overwhelmed. Practicing self-care and prioritizing mental health during this time is essential for maintaining balance and truly enjoying